The MTC-GBM subtype, corresponding to the A172 cell line expression profile, showed upregulation of SOD1 expression and significant correlation with antioxidant gene expressions, predominantly with the PRDX family, PRDX1-5, and with TXNRD1. The gene discussed is TXNRD1; the disease is medullary thyroid gland carcinoma.